Selective ablation of human T-cell lymphotropic virus type 1 p12(I) reduces viral infectivity in vivo

Blood

Volumn 91, Issue 12, 1998, Pages 4701-4707

  Collins, Nathaniel D ^b   Newbound, Garret C ^b   Albrecht, Björn ^b   Beard, Jennifer L ^b   Ratner, Lee ^a   Lairmore, Michael D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE;

ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LIFE CYCLE; OPEN READING FRAME; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE DIAGNOSIS; RABBIT; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SPINAL CORD DISEASE; T CELL LEUKEMIA; VIRUS CULTURE; VIRUS INFECTION; VIRUS TRANSFORMATION;

EID: 0031864188     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4701.412k23_4701_4707     Document Type: Article

References (34)

1. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031, 1982
2. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031, 1986
3. Green PL, Chen ISY: Molecular features of the human T-cell leukemia virus. Mechanisms of transformation and leukemogenicity, in Levy JA (ed): The Retroviridae. New York, NY, Plenum, 1994, p 277
4. Yoshida M: Molecular biology of HTLV-I: Recent progress. J Acq Immun Defic Synd Hum R 13:S63, 1996
5. Hidaka M, Inoue J, Yoshida M, Seiki M: Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J 7:519, 1988
6. Berneman ZN, Gartenhaus RB, Reitz MS, Blattner WA, Manns A, Hanchard B, Ikehara O, Gallo RC, Klotman ME: Expression of alternatively spliced human T-lymphotropic virus type 1 pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci USA 89:3005, 1992
7. Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK: Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I. J Virol 66:1737, 1992
8. Koralnik IJ, Gessain A, Klotman ME, Lo Monico A, Berneman ZN, Franchini G: Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type 1. Proc Natl Acad Sci USA 89:8813, 1992
9. Cereseto A, Berneman Z, Koralnik I, Vaughn J, Franchini G, Klotman ME: Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia 11:866, 1997
10. Koralnik IJ, Fullen J, Franchini G: The p 12, p13 and p30 proteins encoded by human T-cell leukemia/lymphotropic virus type-1 open reading frames I and II are localized in three different cellular compartments. J Virol 67:2360, 1993
11. Franchini G: Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection. Blood 86:3619, 1995
12. +ATPase. J Virol 67:7701, 1993
13. c chains and affects their expression on the cell surface. J Virol 70:3599, 1996
14. Willems L, Kerkhofs P, Dequiedt F, Portetelle D, Mammerickx M, Burny A, Kettmann R: Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci USA 91:11532, 1994
15. Cockerell GL, Rovnak J, Green PL, Chen ISY: A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. Blood 87:1030, 1996
16. Green PL, Ross TM, Chen ISY, Pettiford S: Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J Virol 69:387, 1995
17. + lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1. J Virol 70:7241, 1996
18. + T lymphocytes. J Virol 70:2101, 1996
19. Kimata JT, Wong F, Wang J, Ratner L: Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204:656, 1994
20. Lairmore MD, Digeorge AM, Conrad SF, Trevino AV, Lal RB, Kaumaya PTP: Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction. J Virol 69:6077, 1995
21. Andrews JM, Oglesbee MJ, Trevino AV, Guyot DJ, Newbound GC, Lairmore MD: Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response. Virology 208:816, 1995
22. Lion T: Control genes in reverse transeriptase-polymerase chain reaction assays. Leukemia 11:872, 1997
23. Lairmore MD, Jacobson S, Gracia F, De B, Castillo L, Larreategui M, Roberts BD, Levine P, Blattner W, Kaplan JE: Isolation of human T-lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 87:8840, 1990
24. Miyoshi I, Yoshimoto S, Kubonishi I, Fujishita M, Ohtsuki Y, Yamashita M, Yamato K, Hirose S, Taguchi H, Niiya K, Kobayashi M: Infectious transmission of human T-cell leukemia virus to rabbits. Int J Cancer 35:81, 1985
25. Lairmore MD, Roberts B, Frank D, Rovnak J, Weiser MG, Cockerell GL: Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease. Int J Cancer 50: 124, 1992
26. Cockerell GL, Lairmore MD, De B, Rovnak J, Hartley T, Miyoshi I: Persistent infection of rabbits with HTLV-I: Patterns of anti-viral reactivity and detection of virus by gene amplification. Int J Cancer 45:127, 1990
27. Iwahara Y, Takehara N, Kataoka R, Sawada T, Ohtsuki Y, Nakachi H, Maehama T, Okayama T, Miyoshi I: Transmission of HTLV-1 to rabbits via semen and breast milk from seropositive healthy persons. Int J Cancer 45:980, 1990
28. Kotani S, Yoshimoto S, Yamato K, Fujishita M, Yamashita M, Ohtsuki Y, Taguchi H, Miyoshi I: Serial transmission of human T-cell leukemia virus type 1 by blood transfusion in rabbits and its prevention by use of X-irradiated stored blood. Int J Cancer 37:843, 1986
29. Yoshida M: Expression of the HTLV-1 genome and its association with a unique T-cell malignancy. Biochim Biophys Acta 907:145, 1987
30. Kestler HW, Ringler DJ, Mon K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC: Importance of the nef gene for maintenance of high viral loads and for the development of AIDS. Cell 65:651, 1991
31. Chou J, Kern ER, Whitley RJ, Roizman B: Mappping of herpes simplex virus I neurovirulence to ICP34.5, a gene nonessential for growth in cell culture. Science 252:1262, 1990
32. Migone TS, Lin JX, Cereseto A, Mulloy JC, Oshea JJ, Franchini G, Leonard WJ: Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79, 1995
33. Xu X, Kang SH, Heidenreich O, Okerholm M, Oshea JJ, Nerenberg MI: Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J Clin Invest 96:1548, 1995
34. Ciminale V, Zotti L, Dagostino DM, Chiecobianchi L: Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs. J Virol 71:2810, 1997